Search by Drug Name or NDC

    NDC 00713-0728-53 Betamethasone Dipropionate 0.5 mg/mL Details

    Betamethasone Dipropionate 0.5 mg/mL

    Betamethasone Dipropionate is a TOPICAL LOTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is BETAMETHASONE DIPROPIONATE.

    Product Information

    NDC 00713-0728
    Product ID 0713-0728_dde30fad-5417-07e5-e053-2a95a90a8883
    Associated GPIs 90550020004105
    GCN Sequence Number 007570
    GCN Sequence Number Description betamethasone dipropionate LOTION 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 31080
    HICL Sequence Number 003304
    HICL Sequence Number Description BETAMETHASONE DIPROPIONATE
    Brand/Generic Generic
    Proprietary Name Betamethasone Dipropionate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Betamethasone Dipropionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LOTION
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/mL
    Substance Name BETAMETHASONE DIPROPIONATE
    Labeler Name Cosette Pharmaceuticals, Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA071467
    Listing Certified Through n/a

    Package

    NDC 00713-0728-53 (00713072853)

    NDC Package Code 0713-0728-53
    Billing NDC 00713072853
    Package 1 BOTTLE in 1 CARTON (0713-0728-53) / 60 mL in 1 BOTTLE
    Marketing Start Date 2018-08-24
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.37947
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description BETAMETHASONE DP 0.05% LOT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis